Frederic Luciano

Nice, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 41 publications

Connective tissue growth factor contributes to resistance to anti-angiogenic therapies in renal cancer.

Connective tissue growth factor contributes to resistance to anti-angiogenic therapies in renal cancer.

Journal: Theranostics

Published: September 16, 2025

Enhancing radiotherapy techniques for Triple-Negative breast cancer treatment.

Enhancing radiotherapy techniques for Triple-Negative breast cancer treatment.

Journal: Cancer treatment reviews

Published: January 31, 2025

Comparative impact of proton versus photon irradiation on triple-negative breast cancer: Role of VEGFC in tumour aggressiveness.

Comparative impact of proton versus photon irradiation on triple-negative breast cancer: Role of VEGFC in tumour aggressiveness.

Journal: Clinical and translational medicine

Published: November 22, 2024

Disrupting USP39 deubiquitinase function impairs the survival and migration of multiple myeloma cells through ZEB1 degradation.

Disrupting USP39 deubiquitinase function impairs the survival and migration of multiple myeloma cells through ZEB1 degradation.

Journal: Journal of experimental & clinical cancer research : CR

Published: July 12, 2024

Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001.

Unveiling CXCR2 as a promising therapeutic target in renal cell carcinoma: exploring the immunotherapeutic paradigm shift through its inhibition by RCT001.

Journal: Journal of experimental & clinical cancer research : CR

Published: November 13, 2023

Opposing Roles of Vascular Endothelial Growth Factor C in Metastatic Dissemination and Resistance to Radio/Chemotherapy: Discussion of Mechanisms and Therapeutic Strategies.

Opposing Roles of Vascular Endothelial Growth Factor C in Metastatic Dissemination and Resistance to Radio/Chemotherapy: Discussion of Mechanisms and Therapeutic Strategies.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: April 22, 2022

Targeting of c-MET and AXL by cabozantinib is a potential therapeutic strategy for patients with head and neck cell carcinoma.

Targeting of c-MET and AXL by cabozantinib is a potential therapeutic strategy for patients with head and neck cell carcinoma.

Journal: Cell reports. Medicine

Published: June 30, 2021

The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy.

The Polo-like kinase 1 inhibitor onvansertib represents a relevant treatment for head and neck squamous cell carcinoma resistant to cisplatin and radiotherapy.

Journal: Theranostics

Published: April 16, 2021

Targeting acute myeloid leukemia dependency on VCP-mediated DNA repair through a selective second-generation small-molecule inhibitor.

Targeting acute myeloid leukemia dependency on VCP-mediated DNA repair through a selective second-generation small-molecule inhibitor.

Journal: Science translational medicine

Published: December 12, 2020

Retraction Note: LAMP2 expression dictates azacytidine response and prognosis in MDS/AML.

Retraction Note: LAMP2 expression dictates azacytidine response and prognosis in MDS/AML.

Journal: Leukemia

Published: July 16, 2020

Dual Covalent Inhibition of PKM and IMPDH Targets Metabolism in Cutaneous Metastatic Melanoma.

Dual Covalent Inhibition of PKM and IMPDH Targets Metabolism in Cutaneous Metastatic Melanoma.

Journal: Cancer research

Published: June 22, 2020

Implication and Regulation of AMPK during Physiological and Pathological Myeloid Differentiation.

Implication and Regulation of AMPK during Physiological and Pathological Myeloid Differentiation.

Journal: International journal of molecular sciences

Published: September 06, 2018

Showing 1-12 of 41

Last Updated: 09/26/2026